By 2023, the veterinary vaccine market in El Salvador, excluding foot-and-mouth diseases, was valued at $23.045 million. From 2013 to 2013, the market exhibited moderate growth, marked by fluctuations, with the highest growth perceived in 2015 and 2018. Although there was a decrease in 2019, the market rebounded and displayed consistent growth towards 2023.
Year-on-year changes averaged around 3% over the last two years. The Compound Annual Growth Rate (CAGR) for the past five years was approximately 2.03% – reflecting a steady increase within a competitive and evolving industry.
Future trends to monitor include the impact of technological advancements in vaccine development, increased awareness of animal health, and governmental policies supporting veterinary health. These may offer opportunities for further market expansion.
